Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
– Company to host live webcast and conference call Monday, December 15,…
Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods
BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian…
Miltenyi Biotec Receives ‘Special Recognition Award’ for Pioneering Work in Cell & Gene Therapy at BioSpectrum India Excellence Awards 2025
NEW DELHI, Dec. 9, 2025 /PRNewswire/ -- Miltenyi Biotec has been honoured…
CGTN: In the wake of tragedy, Hong Kong comes together to rebuild
BEIJING, Dec. 9, 2025 /PRNewswire/ -- CGTN published an article on the…
Anderson Diagnostics and MAHE Launch Groundbreaking Centre of Excellence in Reproductive Genomics
Anderson Diagnostics & Labs, Chennai, in a landmark partnership with Manipal Academy…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…
Berlin Heals Welcomes Rob ten Hoedt as New Chairman of the Board
ZUG, Switzerland, Dec. 10, 2025 /PRNewswire/ -- Berlin Heals Holding AG (Zug, Switzerland)…
Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor
CAMBRIDGE, Mass., Dec. 9, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today…
Genesis Healthcare Remains Committed to Securing Longterm Stability
KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court…